Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.12 USD | +1.41% | +0.89% | -20.32% |
Strengths
- The company's share price in relation to its net book value makes it look relatively cheap.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- With a 2024 P/E ratio at 24.73 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-20.32% | 3.24B | B- | ||
-5.76% | 182B | C+ | ||
+1.82% | 111B | C | ||
-3.66% | 68.48B | A | ||
+0.26% | 49.69B | B- | ||
+7.70% | 44.46B | B- | ||
+2.33% | 40.67B | B+ | ||
+22.58% | 31.22B | B | ||
+1.66% | 26.09B | A- | ||
+15.30% | 25.32B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- NVST Stock
- Ratings Envista Holdings Corporation